Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Cellevate CEO discusses scale up and boost viral vector production needs for biotech and partnerships at BIO-Europe 2024
December 17, 2024
Laura Chirica, CEO of Cellevate walks through the company’s recent launch of its nanofiber-based cell culture systems starter pack. Cellevate is coming to the bioprocessing industry with a disruptive technology that offers 60% more surface area for cells to grow, according to the company. The company’s vision is be a part of accelerating the biomanufacturing revolution.